Skip to main content
Fig. 6 | Molecular Cancer

Fig. 6

From: Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma

Fig. 6

Neither loss of DG glycosylation nor expression assessed by immunohistochemistry associates with disease recurrence. Following scoring, data was compiled and analyzed comparing patients experiencing disease recurrence and those that remained disease-free. Neither αDG (a, b) nor βDG (c, d) demonstrated a significant association with disease recurrence when analyzed by Fisher’s exact test (a, c) or by log-rank assessment (b, d)

Back to article page

Molecular Cancer

ISSN: 1476-4598